Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
Sign Up to like & getrecommendations! Published in 2023 at "Geburtshilfe und Frauenheilkunde"
DOI: 10.1055/a-2073-1887
Abstract: Abstract In patients with existing ovarian function, there are some special aspects to adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive, HER2-negative (HR pos./HER2 neg.) breast cancer. Treatment options include tamoxifen with or without… read more here.
Keywords: therapy premenopausal; her2; therapy; mit ... See more keywords